+987.9%
MRNA vs NVTS
-9.1%
+997.0%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | NVTS | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +9.0% | +4.1% | +11.8% |
| 7D | +20.6% | -0.3% | +21.0% | +20.6% |
| 30D | +27.1% | -24.4% | +51.5% | +31.3% |
| 3M | +353.4% | -26.5% | +379.9% | +366.7% |
| 6M | +446.3% | -41.4% | +487.7% | +463.3% |
| YTD | +776.2% | +30.7% | +745.5% | +665.1% |
| 1Y | +987.9% | -10.8% | +998.7% | +884.3% |
| All | +987.9% | -9.1% | +997.0% | +884.3% |
Cumulative growth
Daily Returns
Daily percentage return beside NVTS.
Daily Out/Under-Performance
Portfolio return minus NVTS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NVTS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded NVTS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling